Jamie N Bakkum-Gamez et al.
Gynecologic oncology, 108(1), 141-148 (2007-11-09)
Müllerian inhibiting substance type II receptor (MISIIR) is expressed by ovarian, breast, and prostate cancers [Masiakos PT, et al. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) Type II Receptor, bind, and